Literature DB >> 6193905

Time-resolved fluoroimmunoassay of human pancreatic phospholipase A2.

J U Eskola, T J Nevalainen, T N Lövgren.   

Abstract

We describe an immunofluorometric assay for human pancreatic phospholipase A2 based on time-resolved fluorescence. The labeled antibody technique in combination with the time-resolved 1-s fluorometric detection of the europium label, which essentially eliminates all background fluorescence, resulted in a high sensitivity (20 ng/L) and a wide (5000-fold) linear range. Nonspecific binding was minimized by treating the solid-phase antibody with NaSCN before coating, to remove endogenous antigen, and by immunosorbent purification of the antibody before labeling with europium. This is a one-incubation, multi-site, solid-phase assay on polystyrene microtiter strips, even though a polyclonal antibody was used. As measured by this assay, activity of immunoreactive phospholipase A2 was found to be above normal in sera of patients suffering from acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6193905

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  17 in total

1.  The role of phospholipase A2 in pancreatic acinar cell injury.

Authors:  A J Hietaranta; Z G Lászik; H J Aho; P T Kortesuo; T J Nevalainen
Journal:  Int J Pancreatol       Date:  1991-02

2.  Diagnostic value of immunoreactive phospholipase A2 in acute pancreatitis.

Authors:  P Malfertheiner; T Nevalainen; W Uhl; H Schädlich; M Büchler
Journal:  Klin Wochenschr       Date:  1989-02-01

3.  Necrosectomy and postoperative local lavage in patients with necrotizing pancreatitis: results of a prospective clinical trial.

Authors:  H G Beger; M Büchler; R Bittner; W Oettinger; S Block; T Nevalainen
Journal:  World J Surg       Date:  1988-04       Impact factor: 3.352

Review 4.  Laboratory tests in the diagnosis of the chronic pancreatic diseases. Part 4. Tests involving the measurement of pancreatic enzymes in body fluid.

Authors:  E J Boyd; H Rinderknecht; K G Wormsley
Journal:  Int J Pancreatol       Date:  1988 Jan-Feb

5.  Elevation of serum phospholipase A2 in patients at an intensive care unit.

Authors:  M Kitagawa; T Hayakawa; T Kondo; T Shibata; Y Sakai; H Sobajima; H Ishiguro; M Tanikawa; Y Nakae; S Kameya
Journal:  Int J Pancreatol       Date:  1991 Nov-Dec

6.  Pancreatic and synovial type phospholipases A2 in serum samples from patients with severe acute pancreatitis.

Authors:  T J Nevalainen; J M Grönroos; P T Kortesuo
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

7.  Phospholipase A2 in human ascitic fluid. Purification, characterization and immunochemical detection.

Authors:  P T Kortesuo; T J Nevalainen
Journal:  Biochem J       Date:  1991-08-15       Impact factor: 3.857

8.  Urinary phospholipase A2 excretion in chronic pancreatic diseases.

Authors:  C Fabris; D Basso; M P Panozzo; G Del Favero; T Meggiato; M Plebani; C Ferrara; P Fogar; M Zaninotto; R Naccarato
Journal:  Int J Pancreatol       Date:  1992-06

9.  Serum phospholipase A2 in intensive care patients with peritonitis, multiple injury, and necrotizing pancreatitis.

Authors:  M Büchler; A Deller; P Malfertheiner; H O Kleine; H Wiedeck; W Uhl; M Samtner; H Friess; T Nevalainen; H G Beger
Journal:  Klin Wochenschr       Date:  1989-02-01

10.  Prognostic value of serum phospholipase A in acute pancreatitis.

Authors:  M Büchler; P Malfertheiner; H Schädlich; T Nevalainen; T Mavromatis; H G Beger
Journal:  Klin Wochenschr       Date:  1989-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.